![]() ![]() 108010001801 Tumor Necrosis Factor-alpha Proteins 0.000 claims description 232.102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 232.238000002360 preparation method Methods 0.000 claims abstract description 87. ![]() 230000000694 effects Effects 0.000 claims abstract description 128.239000000463 material Substances 0.000 claims abstract description 130.108090000623 proteins and genes Proteins 0.000 claims abstract description 161.102000004169 proteins and genes Human genes 0.000 claims abstract description 161.239000000203 mixture Substances 0.000 claims abstract description 268.108090001123 antibodies Proteins 0.000 claims abstract description 907.102000004965 antibodies Human genes 0.000 claims abstract description 907.238000011091 antibody purification Methods 0.000 title description 4.Publication of RU2008143356A publication Critical patent/RU2008143356A/en Application granted granted Critical Publication of RU2466740C2 publication Critical patent/RU2466740C2/en First worldwide family litigation filed litigation Critical (C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Family has litigation Priority to US78972506P priority Critical Priority to US60/789,725 priority Priority to US79041406P priority Priority to US60/790,414 priority Application filed by Эбботт Байотекнолоджи Лтд. Priority date (The priority date is an assumption and is not a legal conclusion. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |